There is broad consensus that widespread SARS-CoV-2 testing is essential to safely reopening the United States. A big concern has been test availability, but test accuracy may prove a larger long-term ...
Engineered M13 phage-based biosensor offers rapid, label-free detection of SARS-CoV-2 spike protein, demonstrating femtogram-level sensitivity in tests.
The biosensing platform developed by Penn State engineering researchers incorporates two-pass laser induced graphene with commercial transistors to simultaneously test for SARS-CoV-2 and vitamin C.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results